Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 403

1.

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.

Clin Exp Allergy. 2012 Jun;42(6):929-35. doi: 10.1111/j.1365-2222.2012.03984.x.

PMID:
22909164
2.

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):49-53. doi: 10.1016/j.anai.2011.10.017. Epub 2011 Nov 21.

PMID:
22192966
3.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):354-61. doi: 10.2500/aap.2012.33.3589.

PMID:
22856636
4.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.

Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy. 2011 Dec;66(12):1604-11. doi: 10.1111/j.1398-9995.2011.02702.x. Epub 2011 Sep 2.

5.

Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.

Riedl M.

Clin Drug Investig. 2015 Jul;35(7):407-17. doi: 10.1007/s40261-015-0300-z. Review.

6.

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.

Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL.

Ann Allergy Asthma Immunol. 2013 Apr;110(4):295-9. doi: 10.1016/j.anai.2013.02.007. Epub 2013 Mar 6.

PMID:
23535096
7.

C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.

Schneider L, Hurewitz D, Wasserman R, Obtulowicz K, Machnig T, Moldovan D, Reshef A, Craig TJ.

Pediatr Allergy Immunol. 2013 Feb;24(1):54-60. doi: 10.1111/pai.12024. Epub 2012 Nov 22.

PMID:
23173714
8.

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

Farkas H, Csuka D, Veszeli N, Zotter Z, Szabó E, Varga L.

Allergy Asthma Proc. 2014 May-Jun;35(3):255-9. doi: 10.2500/aap.2014.35.3743.

PMID:
24801469
9.

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.

Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtułowicz K, Reshef A, Ritchie B, Moldovan D, Shirov T, Grivcheva-Panovska V, Kiessling PC, Keinecke HO, Bernstein JA.

J Allergy Clin Immunol. 2009 Oct;124(4):801-8. doi: 10.1016/j.jaci.2009.07.017. Epub 2009 Sep 19.

PMID:
19767078
10.

Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.

Craig TJ, Rojavin MA, Machnig T, Keinecke HO, Bernstein JA.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):211-5. doi: 10.1016/j.anai.2013.06.021. Epub 2013 Jul 16.

PMID:
23987198
11.

Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):517-21. doi: 10.2500/ajra.2013.27.3973.

PMID:
24274230
12.

Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.

Lumry W, Manning ME, Hurewitz DS, Davis-Lorton M, Fitts D, Kalfus IN, Uknis ME.

J Pediatr. 2013 May;162(5):1017-22.e1-2. doi: 10.1016/j.jpeds.2012.11.030. Epub 2013 Jan 11.

PMID:
23312695
14.

Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.

Lumry W, Soteres D, Gower R, Jacobson KW, Li HH, Chen H, Schranz J.

Pediatr Allergy Immunol. 2015 Nov;26(7):674-80. doi: 10.1111/pai.12444. Epub 2015 Aug 11.

PMID:
26171584
15.

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.

Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S, Haase G, Kaufman L, Hack CE.

J Allergy Clin Immunol. 2010 Oct;126(4):821-827.e14. doi: 10.1016/j.jaci.2010.07.021.

PMID:
20920772
16.

Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.

Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1091-1097. doi: 10.1016/j.jaip.2016.11.005. Epub 2017 Feb 13.

17.

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Heller C, Klingebiel T.

Transfusion. 2009 Sep;49(9):1987-95. doi: 10.1111/j.1537-2995.2009.02230.x. Epub 2009 May 20.

PMID:
19497056
18.

Recombinant human c1 inhibitor (conestat alfa): in the treatment of angioedema attacks in hereditary angioedema.

Plosker GL.

BioDrugs. 2012 Oct 1;26(5):315-23. doi: 10.2165/11206880-000000000-00000. Review.

PMID:
22946752
19.

New treatment options for acute edema attacks caused by hereditary angioedema.

Thomas MC, Shah S.

Am J Health Syst Pharm. 2011 Nov 15;68(22):2129-38. doi: 10.2146/ajhp100718. Review.

PMID:
22058099
20.

Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.

Riedl MA, Li HH, Cicardi M, Harper JR, Relan A.

Allergy Asthma Proc. 2017 Nov 13;38(6):462-466. doi: 10.2500/aap.2017.38.4090. Epub 2017 Sep 13.

PMID:
28903805

Supplemental Content

Support Center